跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 56 条关于
“MC1r”
全部
56
临床试验
22
药物
11
机构
1
资讯
22
2年前
FDA Grants Fast Track Designation to VMT01 for MC1R-Positive Melanoma
去年
Palatin's Oral MC1R Agonist Shows Promising Results in Phase 2 Ulcerative Colitis Trial
9个月前
Alpha-9 Oncology Initiates Phase 1 Trial of Novel Actinium-225 Radiotherapeutic for Melanoma
去年
Alpha-9 Oncology Secures $175M in Series C Funding to Advance Radiopharmaceutical Pipeline
去年
Perspective Therapeutics Advances Radiopharmaceutical Pipeline, Reports Promising Early Clinical Data
去年
Palatin's Melanocortin Agonist Shows Promising Results in Phase 2b Diabetic Kidney Disease Trial
2年前
Afamelanotide Under Evaluation for Vitiligo Treatment in Phase 3 Trial
去年
Perspective Therapeutics and PMV Pharma Provide Clinical Trial Updates
去年
Perspective Therapeutics Doses First Patient in Combination Therapy Trial for Advanced Melanoma
上个月
LEO Pharma Acquires Worldwide Rights to Dersimelagon for Up to $435 Million
第 1 页,共 3 页
上一页
下一页